Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a ...

After hours: 7 March at 18:06:57 GMT-5 Loading Chart for MTNB ...

Long-term partnership includes capacity from the Telesat Lightspeed Low Earth Orbit (LEO) constellation for integration into Orange Wholesale's portfolio of solutions for businesses and telecom ...

The global oral vaccines market is poised for remarkable expansion, with revenue projected to grow from USD 3,985.9 million in 2024 to USD 8,800 million by 2033. This strong growth, reflected in a ...

CAMBRIDGE, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announced the ...

But the promise of AI in biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties. For this year’s State of Tech in Biopharma report, we were deeply ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

After hours: 7:54:05 p.m. EDT Loading Chart for LCTX ...